TESTOSTERONE ENANTHATE | N209863 | ANTARES PHARMA INC
Highest NADAC/Unit
$317.02
per ml
Lowest NADAC/Unit
$315.32
per ml
Brand NDCs
3
Generic NDCs
0
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 54436020004XYOSTED 100 MG/0.5 ML AUTO-INJ | $317.02 | ML | Brand | — | 2026-06-17 |
| 54436027504XYOSTED 75 MG/0.5 ML AUTO-INJ | $316.49 | ML | Brand | — | 2026-06-17 |
| 54436025004XYOSTED 50 MG/0.5 ML AUTO-INJ | $315.32 | ML | Brand | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8021335 | Oct 4, 2026 | — | — | Yes | — | — |
| 8562564 | Jan 24, 2026 | — | — | Yes | — | — |
| 9180259 | Jan 24, 2026 | — | — | Yes | — | — |
| 9533102 | Jan 24, 2026 | — | — | Yes | — | — |
| 9629959 | Jan 24, 2026 | — | — | Yes | — | — |
| 9744302 | Nov 19, 2035 | — | — | Yes | — | — |
| 9950125 | Sep 4, 2036 | — | — | Yes | — | |
| 10238662 | Feb 19, 2035 | — | — | Yes | — | |
| 10279131 | Jul 31, 2031 | — | — | Yes | — | — |
| 10357609 | Aug 21, 2031 | — | — | Yes | — | — |
| 10478560 | Jan 24, 2026 | — | — | Yes | — | — |
| 10646495 | Aug 30, 2038 | — | — | Yes | — | — |
| 10821072 | Jun 4, 2033 | — | — | Yes | — | |
| 10881798 | Feb 11, 2034 | — | — | Yes | — | — |
| 10905827 | Aug 21, 2031 | — | — | Yes | — | — |
| 10912782 | Feb 19, 2035 | — | — | Yes | — | |
| 11160751 | Oct 7, 2034 | — | — | Yes | — | |
| 11191908 | Oct 18, 2035 | — | — | Yes | — | — |
| 11446440 | Aug 21, 2031 | — | — | Yes | — | — |
| 11446441 | Jan 24, 2026 | — | — | Yes | — | — |
| 11497753 | Mar 19, 2030 | — | — | Yes | — | — |
| 11813435 | Feb 25, 2035 | — | — | Yes | — | — |
| 11844804 | Jun 4, 2033 | — | — | — | — | |
| 12629483 | Aug 7, 2035 | — | — | Yes | — | — |